Marjolein van Egmond

PROF.DR., (Principal Investigator)

20082019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

  • 57 Article
  • 9 Research VU University Amsterdam, graduation VU University Amsterdam
  • 5 Review article
  • 3 Meeting Abstract

CD62L Is a Functional and Phenotypic Marker for Circulating Innate Lymphoid Cell Precursors

Bar-Ephraim, Y. E., Koning, J. J., Burniol Ruiz, E., Konijn, T., Mourits, V. P., Lakeman, K. A., Boon, L., Bögels, M., van Maanen, J. P., Den Haan, J. M. M., van Egmond, M., Bouma, G., Reijmers, R. M. & Mebius, R. E., 1 Jan 2019, In : Journal of Immunology. 202, 1, p. 171-182 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Efficient Innate Immune Killing of Cancer Cells Triggered by Cell-Surface Anchoring of Multivalent Antibody-Recruiting Polymers

Uvyn, A., de Coen, R., Gruijs, M., Tuk, C. W., de Vrieze, J., van Egmond, M. & de Geest, B. G., 9 Sep 2019, In : Angewandte Chemie International Edition in English. 58, 37, p. 12988-12993

Research output: Contribution to journalArticleAcademicpeer-review

FcγRIIIb restricts antibody-dependent destruction of cancer cells by human neutrophils

Treffers, L. W., van Houdt, M., Bruggeman, C. W., Heineke, M. H., Zhao, X. W., van der Heijden, J., Nagelkerke, S. Q., Verkuijlen, P. J. J. H., Geissler, J., Lissenberg-Thunnissen, S., Valerius, T., Peipp, M., Franke, K., van Bruggen, R., Kuijpers, T. W., van Egmond, M., Vidarsson, G., Matlung, H. L. & van den Berg, T. K., 1 Jan 2019, In : Frontiers in Immunology. 10, JAN, 03124.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

IgA and FcαRI: Pathological Roles and Therapeutic Opportunities

Breedveld, A. & van Egmond, M., 1 Jan 2019, In : Frontiers in Immunology. 10, MAR, p. 553 553.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

Mesangial deposition can strongly involve innate-like iga molecules lacking affinity maturation

Wehbi, B., Oblet, C., Boyer, F., Huard, A., Druilhe, A., Paraf, F., Cogné, E., Moreau, J., Makhour, Y. E., Badran, B., van Egmond, M., Cogné, M. & Aldigier, J-C., 1 Jul 2019, In : Journal of the American Society of Nephrology. 30, 7, p. 1238-1249

Research output: Contribution to journalArticleAcademicpeer-review

Activities 2018 2019

  • 14 Invited talk
  • 5 Membership of committee
  • 2 Organising a conference, workshop, ...
  • 1 Examination

French National Research Agency (ANR) (External organisation)

Marjolein van Egmond (Chair)
1 Jan 201931 Dec 2019

Activity: MembershipMembership of committee

Immunoglobulin A: Trojan horse or magic bullet?

Marjolein van Egmond (Keynote speaker)
10 Dec 2019

Activity: Talk or presentationInvited talk

Immunoglobulin A: Trojan horse or magic bullet?

Marjolein van Egmond (Invited speaker)
27 Aug 2019

Activity: Talk or presentationInvited talk

‘Targeting of the IgA Fc receptor in disease’.

Marjolein van Egmond (Invited speaker)
26 Jun 2019

Activity: Talk or presentationInvited talk

IgA in autoimmunity and in therapy.

Marjolein van Egmond (Invited speaker)
17 Jun 2019

Activity: Talk or presentationInvited talk

Press / Media

Neutrofielen inzetten tegen kanker met immunoglobuline A.

Marjolein van Egmond

15/08/2019

1 media contribution

Press/Media: Interview

mijnafweer.nl

Marjolein van Egmond

29/04/2019

1 media contribution

Press/Media: Public Engagement Activities

Libelle article: Feiten & Fabels over kanker

Marjolein van Egmond

08/08/2018

1 media contribution

Press/Media: Public Engagement Activities